Antibody Engineering & Therapeutics hybrid conference took place online and in San Diego. Join us as we take a look back at the highlights from the week.
In December 2021, the Antibody Engineering & Therapeutics hybrid conference took place in San Diego, with a digital experience option for those who couldn't join.
Sessions exploring topics across antibody-based drug production were led by 135+ speakers from around the industry.
The comprehensive program, created in conjunction with the Antibody Society, boasted fascinating insights shared by the likes of Kristian Andersen (Scripps Research), James Wells (UCSF), Aviv Regev (Genentech Research & Early Development) and many more.
Join us as we take a look back at the highlights from the week, including the most captivating keynotes, the scientific poster presentation hall and reflective insights from AbCellera.
Jump to any article using the contents on the following page, or at any time using the Contents menu in the top left. There you can also download this report as a PDF. >>>>>>
Understanding cell-specific cellular networks with Dr Aviv Regev at Genentech Research and Early Development
Exploring origins, variants and vaccines with Prof Kristian Andersen at Scripps Research
Antibody discovery for transmembrane proteins with Dr Roza Bidshahri at AbCellera
Proteomics and antigen discovery with Prof Jim Wells at University of California
Humanized antibodies and computational screening with Prof Charlotte Deane at Oxford University
A whitepaper by AbCellera
Targeting future variants with Dr Laura Walker at Adimab, LLC
A look back at the live and virtual poster presentations at the event
